Raimar Löbenberg
Chairman bij DEFENCE THERAPEUTICS INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
Raimar Löbenberg is the founder of RS Therapeutics, Inc. He currently holds the position of Chairman at Defence Therapeutics Inc and Independent Director at BioNxt Solutions, Inc. He is also the Co-Managing Director at Vektor Pharma TF GmbH.
In addition, he has been a Professor of Pharmacy & Pharmaceutical at the University of Alberta since 2000.
Previously, he served as the President of the Canadian Society for Pharmaceutical Sciences from 2014 to 2015.
Dr. Löbenberg obtained his doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main and his undergraduate degree from The Johannes Gutenberg University of Mainz.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BIONXT SOLUTIONS INC
4.72% | 03-04-2023 | 5 000 000 ( 4.72% ) | 2 M $ | 31-03-2024 |
| 02-11-2023 | 100 000 ( 0.22% ) | 125 000 $ | 31-03-2024 |
Actieve functies van Raimar Löbenberg
| Bedrijven | Functie | Begin |
|---|---|---|
| BIONXT SOLUTIONS INC. | Director/Board Member | 10-12-2018 |
| DEFENCE THERAPEUTICS INC. | Chairman | 05-01-2021 |
| University of Alberta | Corporate Officer/Principal | 01-01-2000 |
| RS Therapeutics, Inc. | Founder | - |
Vektor Pharma TF GmbH
 Vektor Pharma TF GmbH Pharmaceuticals: MajorHealth Technology Vektor Pharma TF GmbH engages in the development and production of transdermal systems. It is a narcotics company that focuses on the research, development and production of therapeutic films for pharmaceuticals, cosmetics and food. The firm offers formulation development, pharmaceutical analysis, machinery for development and production, and consultation products. The company was founded in 2009 and is headquartered in Uttenweiler, Germany. | Chief Executive Officer | - |
Eerdere bekende functies van Raimar Löbenberg
| Bedrijven | Functie | Einde |
|---|---|---|
| Canadian Society for Pharmaceutical Sciences | President | 01-01-2015 |
Opleiding van Raimar Löbenberg
| Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
| The Johannes Gutenberg University of Mainz | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BIONXT SOLUTIONS INC. | Health Technology |
| DEFENCE THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| Canadian Society for Pharmaceutical Sciences | |
| RS Therapeutics, Inc. | |
Vektor Pharma TF GmbH
Vektor Pharma TF GmbH Pharmaceuticals: MajorHealth Technology Vektor Pharma TF GmbH engages in the development and production of transdermal systems. It is a narcotics company that focuses on the research, development and production of therapeutic films for pharmaceuticals, cosmetics and food. The firm offers formulation development, pharmaceutical analysis, machinery for development and production, and consultation products. The company was founded in 2009 and is headquartered in Uttenweiler, Germany. | Health Technology |
